EMARKET STORAGE - Teleborsa

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market

Protocollo

85173

Comunicato

20201001_85173.pdf

Azienda

DIASORIN

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Thu, 10/01/2020 - 09:45

Data ricezione SDIR

Thu, 10/01/2020 - 09:44

Data embargo SDIR

Thu, 10/01/2020 - 09:44

Data diffusione SDIR

Thu, 10/01/2020 - 09:45

Mercato

Euronext Milan